ARCHIVES

FDA Committee Agenda Includes M-AMSA, THC, Estramustine, Platinum

This article is from The Cancer Letter archive.

Vol. 07 No. 21 | May 22, 1981

Download PDF Visit The Full Archive

Related Articles

SAIC Begins Transition Of Frederick Operations From Incumbent PRI

March 17, 1995

ASCO to Present 2013 Special Awards at Annual Meeting

May 31, 2013

RFP Suggestions For Immunodiagnosis Research Offered

October 22, 1976

In Brief: Lou Carrese, NCI Associate Director, Dies; Myers, Ransahoff Head Two New Organ Systems Group

May 9, 1986

HHS Appoints 13 To Genetics Committee

January 17, 2003

Cancer Epidemiology Hampered By Bureaucratic Delays, Lack of Cooperation, NCI Group Says

September 29, 1978